Axol Bioscience Sporadic Alzheimer’s Disease Line Collection
Available for customer manufacturing of functional cortical excitatory neurons, cortical inhibitory neurons, microglia, and astrocytes
Axol Bioscience, in partnership with StrataStem, has announced the release of a collection of induced pluripotent stem cell (iPSC) lines derived from patients with sporadic Alzheimer’s Disease (sAD).
This ‘Axol Bioscience Sporadic Alzheimer’s Disease Line Collection’ is available for use in Axol’s custom iPSC-derived cell manufacturing program and represents a significant advancement in the tools available for pre-clinical in vitro model building and drug discovery research.
The collection features 20 fully characterized iPSC lines, including both sAD patients and healthy donor controls, all obtained with full ethical and commercial consent from donors in the Greater Manchester area of the UK. These cell lines are particularly valuable for researchers as they represent age-relevant, gender-mixed samples with comprehensive documentation of ApoE genotypes, medical histories, and family histories.
For more information, contact us at operations@axolbio.com
